{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:29:02Z","timestamp":1793665742432,"version":"4.5.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["225328"],"award-info":[{"award-number":["225328"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tcm.2026.03.009","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:01:49Z","timestamp":1775026909000},"page":"500-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Anticoagulation and thromboembolic risk management in pharmacological and electrical cardioversion of atrial fibrillation: State of the evidence and knowledge gaps"],"prefix":"10.1016","volume":"36","author":[{"given":"Nicolas","family":"Johner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Notaristefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Vlachos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"T\u00e9treault-Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Benali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Ditac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Sacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josselin","family":"Duchateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Tixier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pambrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Derval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ja\u00efs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2026.03.009_bib0001","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2026.03.009_bib0002","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2026.03.009_bib0003","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.7326\/ANNALS-25-00253","article-title":"Catheter and surgical ablation for atrial fibrillation : A systematic review and meta-analysis","volume":"178","author":"Montan\u00e9","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tcm.2026.03.009_bib0004","first-page":"ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0005","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2026.03.009_bib0006","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCIMAGING.112.000153","article-title":"Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: a meta-analysis","volume":"6","author":"Romero","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2026.03.009_bib0007","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jcmg.2023.12.009","article-title":"Left atrial imaging prior to cardioversion: leveraging computed tomography to rule out thrombus (LACLOT)","volume":"17","author":"Chow","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.tcm.2026.03.009_bib0008","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM196308152690701","article-title":"Cardioversion\u201d of atrial fibrillation. A report on the treatment of 65 episodes in 50 patients","volume":"269","author":"Lown","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2026.03.009_bib0009","doi-asserted-by":"crossref","first-page":"euae131","DOI":"10.1093\/europace\/euae131","article-title":"Thromboembolic and bleeding complications after elective cardioversion of atrial fibrillation: a nationwide cohort study","volume":"26","author":"It\u00e4inen-Str\u00f6mberg","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2026.03.009_bib0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2021.12.035","article-title":"The risk and timing of acute ischemic stroke after electrical cardioversion for atrial fibrillation in Taiwan: A nationwide population-based cohort study","volume":"351","author":"Huang","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0011","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0002-9149(98)00704-8","article-title":"Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis","volume":"82","author":"Berger","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0012","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0002-9149(69)90068-X","article-title":"The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation","volume":"23","author":"Bjerkelund","year":"1969","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0013","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0735-1097(92)90530-Z","article-title":"Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter","volume":"19","author":"Arnold","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0002-8703(95)90045-4","article-title":"Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: an analysis of pooled trials","volume":"129","author":"Moreyra","year":"1995","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/europace\/euu189","article-title":"Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy","volume":"17","author":"Hansen","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2026.03.009_bib0016","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2016.09.126","article-title":"New oral anticoagulants versus Warfarin in patients undergoing cardioversion of atrial fibrillation","volume":"225","author":"And\u00f2","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0017","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1093\/eurheartj\/ehz521","article-title":"Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials","volume":"40","author":"McIntyre","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0018","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.amjmed.2004.06.048","article-title":"Atrial flutter and the risk of thromboembolism: a systematic review and meta-analysis","volume":"118","author":"Ghali","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.tcm.2026.03.009_bib0019","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0033-0620(60)80005-9","article-title":"The management of chronic atrial fibrillation: indications for and method of conversion to sinus rhythm","volume":"2","author":"Goldman","year":"1960","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.tcm.2026.03.009_bib0020","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.amjcard.2004.06.010","article-title":"Fate of left atrial thrombi in patients with atrial fibrillation determined by transesophageal echocardiography and cerebral magnetic resonance imaging","volume":"94","author":"Bernhardt","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0021","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.3390\/jcm11041128","article-title":"Risk of death and ischemic stroke in patients with atrial arrhythmia and thrombus or sludge in left atrial appendage at one-year follow-up","volume":"11","author":"Kosmalska","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.tcm.2026.03.009_bib0022","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0735-1097(94)00396-8","article-title":"Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study","volume":"25","author":"Stoddard","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0023","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1016\/j.jacc.2021.04.036","article-title":"Prevalence of left atrial thrombus in anticoagulated patients with atrial fibrillation","volume":"77","author":"Lurie","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0024","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ahj.2016.05.007","article-title":"Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)","volume":"178","author":"Lip","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0025","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0735-1097(02)01785-0","article-title":"Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study","volume":"39","author":"Seidl","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0026","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0002-8703(93)91054-I","article-title":"Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients","volume":"126","author":"Black","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0027","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/01.CIR.89.6.2509","article-title":"Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study","volume":"89","author":"Black","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2026.03.009_bib0028","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijcard.2019.09.053","article-title":"Coagulation factors and fibrinolytic activity in the left atrial appendage and other heart chambers in patients with atrial fibrillation: is there a local intracardiac prothrombotic state? (HEART-CLOT study)","volume":"301","author":"Bartus","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0029","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.echo.2005.10.020","article-title":"Cardioversion in patients with left ventricular thrombus is not associated with increased thromboembolic risk","volume":"19","author":"Bangalore","year":"2006","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.tcm.2026.03.009_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108336","article-title":"Safety evaluation of electrical cardioversion in the presence left ventricular thrombus","volume":"34","author":"Dabbagh","year":"2025","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.tcm.2026.03.009_bib0031","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0735-1097(93)90543-A","article-title":"Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography","volume":"22","author":"Grimm","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0032","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9149(96)00333-5","article-title":"Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation","volume":"78","author":"Falcone","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0033","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0002-8703(95)90253-8","article-title":"Left atrial appendage \u201cstunning\u201d after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography","volume":"130","author":"Grimm","year":"1995","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0034","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0735-1097(98)00253-8","article-title":"Left atrial \u201cstunning\u201d following radiofrequency catheter ablation of chronic atrial flutter","volume":"32","author":"Sparks","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0002-8703(90)90079-D","article-title":"Return of atrial mechanical function following electrical conversion of atrial dysrhythmias","volume":"120","author":"O\u2019Neill","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0036","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/0002-9149(88)90260-3","article-title":"Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm","volume":"62","author":"Shapiro","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0037","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/0002-8703(95)90405-0","article-title":"Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation","volume":"129","author":"Stoddard","year":"1995","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0038","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/0735-1097(89)90602-5","article-title":"Pulsed doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation","volume":"13","author":"Manning","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0039","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/0735-1097(94)90652-1","article-title":"Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation","volume":"23","author":"Manning","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0040","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2013.04.089","article-title":"Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study","volume":"62","author":"Airaksinen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0041","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.amjcard.2016.01.024","article-title":"Anticoagulation, CHA2DS2VASc score, and thromboembolic risk of cardioversion of acute atrial fibrillation (from the FinCV Study)","volume":"117","author":"Gr\u00f6nberg","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0042","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jacep.2016.01.018","article-title":"Incidence of thromboembolic complications within 30 days of electrical cardioversion performed within 48 hours of atrial fibrillation onset","volume":"2","author":"Garg","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0043","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.thromres.2017.06.026","article-title":"Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation","volume":"156","author":"Hellman","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.tcm.2026.03.009_bib0044","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0735-1097(02)02052-1","article-title":"Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion","volume":"40","author":"Gallagher","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0045","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.107.697763","article-title":"Intracardiac thrombosis and embolism in patients with cardiac amyloidosis","volume":"116","author":"Feng","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2026.03.009_bib0046","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.jacc.2018.07.098","article-title":"Stroke risk stratification for atrial fibrillation patients with hypertrophic cardiomyopathy","volume":"72","author":"Jung","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0047","first-page":"e7453","article-title":"The frequency of left atrial thrombus on transthoracic echocardiogram in patients with mitral stenosis","volume":"12","author":"Ahmed","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.tcm.2026.03.009_bib0048","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/S0140-6736(16)31474-X","article-title":"Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial","volume":"388","author":"Goette","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2026.03.009_bib0049","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/01.CIR.0000120509.64740.DC","volume":"109","author":"Stellbrink","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2026.03.009_bib0050","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1093\/eurheartj\/ehu367","article-title":"Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation","volume":"35","author":"Cappato","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0051","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/eurheartj\/ehy148","article-title":"Apixaban compared to heparin\/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial","volume":"39","author":"Ezekowitz","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0052","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.110.977546","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion","volume":"123","author":"Nagarakanti","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2026.03.009_bib0053","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/eurheartj\/ehl353","volume":"27","author":"Klein","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0054","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jacc.2018.07.083","article-title":"Direct oral anticoagulants halve thromboembolic events after cardioversion of AF compared with Warfarin","volume":"72","author":"Kotecha","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0055","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11239-018-1622-5","article-title":"Direct oral anti-coagulants compared to vitamin-K antagonists in cardioversion of atrial fibrillation: an updated meta-analysis","volume":"45","author":"Brunetti","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.tcm.2026.03.009_bib0056","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/europace\/eux188","article-title":"Cardioversion of atrial fibrillation in a real-world setting: non-vitamin K antagonist oral anticoagulants ensure a fast and safe strategy compared to warfarin","volume":"20","author":"Frederiksen","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2026.03.009_bib0057","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0140-6736(00)79754-6","article-title":"Arrest of auricular fibrillation by the use of quinidine","volume":"198","author":"Ellis","year":"1921","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2026.03.009_bib0058","doi-asserted-by":"crossref","first-page":"426S","DOI":"10.1378\/chest.102.4_Supplement.426S","article-title":"Antithrombotic therapy in atrial fibrillation","volume":"102","author":"Laupacis","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.tcm.2026.03.009_bib0059","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0002-8703(80)90071-X","article-title":"Cardioversion and defibrillation","volume":"100","author":"DeSilva","year":"1980","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0060","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM200105103441901","article-title":"Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2026.03.009_bib0061","doi-asserted-by":"crossref","first-page":"euae035","DOI":"10.1093\/europace\/euae035","article-title":"Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper","volume":"26","author":"Potpara","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2026.03.009_bib0062","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/clc.22986","article-title":"Optimal timing for cardioversion in patients with atrial fibrillation","volume":"41","author":"Hellman","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0063","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/europace\/eux116","article-title":"Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients undergoing elective cardioversion","volume":"20","author":"It\u00e4inen","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2026.03.009_bib0064","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1001\/jama.2014.3824","article-title":"Time to cardioversion for acute atrial fibrillation and thromboembolic complications","volume":"312","author":"Nuotio","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.tcm.2026.03.009_bib0065","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/europace\/euy310","article-title":"Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis","volume":"21","author":"Um","year":"2019","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2026.03.009_bib0066","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/europace\/eul097","volume":"8","author":"Fuster","year":"2006","journal-title":"Europace"},{"key":"10.1016\/j.tcm.2026.03.009_bib0067","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of atrial fibrillation: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2026.03.009_bib0068","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijcard.2016.12.025","article-title":"Asymptomatic versus symptomatic episodes in patients with paroxysmal atrial fibrillation via long-term monitoring with implantable loop recorders","volume":"231","author":"Simantirakis","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0069","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamainternmed.2013.1561","article-title":"Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study","volume":"173","author":"Verma","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.tcm.2026.03.009_bib0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/hrt.30.1.80","article-title":"Left atrial function after electrical conversion to sinus rhythm","volume":"30","author":"Ikram","year":"1968","journal-title":"Br Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0071","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/hrt.29.4.469","article-title":"Electrical reversion of cardiac arrhythmias","volume":"29","author":"Lown","year":"1967","journal-title":"Br Heart J"},{"key":"10.1016\/j.tcm.2026.03.009_bib0072","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0002-9149(00)01374-6","article-title":"Risk of stroke in patients with atrial flutter","volume":"87","author":"Biblo","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0073","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1067\/mje.2001.109505","article-title":"Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular-weight heparin (enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation","volume":"14","author":"Murray","year":"2001","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.tcm.2026.03.009_bib0074","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.jacc.2013.02.025","article-title":"Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial","volume":"61","author":"Piccini","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2026.03.009_bib0075","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2013.09.062","article-title":"Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)","volume":"63","author":"Flaker","year":"2014","journal-title":"J Am Coll Cardiol"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173826000514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173826000514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:07:25Z","timestamp":1793664445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173826000514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1050173826000514"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2026.03.009","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation and thromboembolic risk management in pharmacological and electrical cardioversion of atrial fibrillation: State of the evidence and knowledge gaps","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2026.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}